Matches in Nanopublications for { <http://rdf.disgenet.org/resource/nanopub/NP1216047.RAqQ6f8zPWx52U-qyNaqWBnvW84j-E7_xjSMpqYSyFxkQ130_assertion> ?p ?o ?g. }
Showing items 1 to 6 of
6
with 100 items per page.
- NP1216047.RAqQ6f8zPWx52U-qyNaqWBnvW84j-E7_xjSMpqYSyFxkQ130_assertion type Assertion NP1216047.RAqQ6f8zPWx52U-qyNaqWBnvW84j-E7_xjSMpqYSyFxkQ130_head.
- NP1216047.RAqQ6f8zPWx52U-qyNaqWBnvW84j-E7_xjSMpqYSyFxkQ130_assertion description "[We found that PON-1-Q192R was associated with severity of RA [remission-to-low and moderate-to-high in dominant Q/Q+Q/R vs. R/R: OR=2.27, p<0.001; codominant Q/Q vs. R/R: OR=1.65, p<0.001 and Q/R vs. R/R: OR=2.12, p=0.003; recessive Q/Q vs. R/R+Q/R: OR=1.79, p=0.032; and allele Q vs. R: OR=1.68, p<0.001] and presence of anti-CCP-antibody (codominant model Q/Q vs. R/R: OR=1.28, p=0.042).]. Sentence from MEDLINE/PubMed, a database of the U.S. National Library of Medicine." NP1216047.RAqQ6f8zPWx52U-qyNaqWBnvW84j-E7_xjSMpqYSyFxkQ130_provenance.
- NP1216047.RAqQ6f8zPWx52U-qyNaqWBnvW84j-E7_xjSMpqYSyFxkQ130_assertion evidence source_evidence_literature NP1216047.RAqQ6f8zPWx52U-qyNaqWBnvW84j-E7_xjSMpqYSyFxkQ130_provenance.
- NP1216047.RAqQ6f8zPWx52U-qyNaqWBnvW84j-E7_xjSMpqYSyFxkQ130_assertion SIO_000772 25179377 NP1216047.RAqQ6f8zPWx52U-qyNaqWBnvW84j-E7_xjSMpqYSyFxkQ130_provenance.
- NP1216047.RAqQ6f8zPWx52U-qyNaqWBnvW84j-E7_xjSMpqYSyFxkQ130_assertion wasDerivedFrom befree-2016 NP1216047.RAqQ6f8zPWx52U-qyNaqWBnvW84j-E7_xjSMpqYSyFxkQ130_provenance.
- NP1216047.RAqQ6f8zPWx52U-qyNaqWBnvW84j-E7_xjSMpqYSyFxkQ130_assertion wasGeneratedBy ECO_0000203 NP1216047.RAqQ6f8zPWx52U-qyNaqWBnvW84j-E7_xjSMpqYSyFxkQ130_provenance.